OUR COMPANY

Leading the future of sterile compounding through quality, innovation, & trust

For decades, we’ve set the standard in 503B outsourcing, building trusted provider partnerships and delivering reliable sterile medications with an unwavering commitment to safety, quality, and patient care.

OUR HISTORY

Excellence in 503B compounding

From our founding as JCB Laboratories in 2002 to becoming one of the first FDA-registered 503B outsourcing facilities in 2014, Fagron Sterile Services US has pioneered advancements in sterile compounding.

1990

Fagron founded in the Netherlands

1990 - 2000

Through a quality focus, Fagron grows to serve more than 30 countries, establishing itself as a global leader in pharmaceutical compounding

2002

JCB Laboratories founded as a small sterile compounding operation on the west side of Wichita, KS, specializing in Ophthalmics

2010

Fagron enters the US market through its nonsterile compounding services and Academy geared toward independent pharmacists

2013

Fagron expands its US operations to include sterile compounding with the acquisition of JCB Laboratories

2014

JCB Laboratories / Fagron become one of the first registered 503B outsourcing facilities in the US

2015

FSS builds a second state-of-the-art 50k+ sq ft 503B Outsourcing facility on the east side of Wichita, KS

2016 - 2019

Product portfolio expansion to support Critical Care medications (OR Syringes); first controlled substance launches (ketamine)

2019

Global rebrand across 70+ sites, JCB and FSS synchronize as Fagron Sterile Services US (FSS)

2020

FSS launches revolutionary repackaged Avastin® syringe and the only Sterile LET Gel (topical anesthetic) through innovative engineering

2021

FSS expands portfolio to include IV bag product presentation and begins strategic partnership with Angels for Change to end drug shortages

2022

FSS acquires Fresenius Kabi's 503B outsourcing business in Boston, MA, adds site in Wichita to support customer needs

2022

FSS introduces RFID embedded OR syringe labels, develops Instant Ship program to support patient care

2022

FSS joins the End Drug Shortages Alliance (EDSA), implements sustainability program reducing annual plastic waste by 2+ tons

2023

FSS grows to support 10s of millions of patient procedures each year

2024

FSS breaks ground on multiple strategic expansion projects to support patient care; a State-of-the-art QC Lab and a project to expand capacity by 40%

2024

FSS acquires Ritedose 503B outsourcing business, expands service to Puerto Rico, and protects Dextrose from shortage with Angels for Change

Why choose FSS

Personalized, cGMP-compliant, 503B outsourcing solutions to meet the unique needs of hospitals, clinics, and ambulatory surgery centers focused on supporting patient care

SUPPLY INNOVATION

Globally and vertically integrated

Fagron operates across 30+ countries from 70+ facilities with over 4,000 employees supporting patient care and advancing patient safety including 503B outsourcing services across the US.

INDUSTRY EXPERIENCE

Customer focused operations

For 34 years Fagron has offered transparency to customers globally; FSS supports peace of mind through virtual and in-person facility visits, partnerships across 60+ industry organizations and top-tier customer service.

CRITICAL CARE, LABOR & DELIVERY, OPHTHALMICS & MORE

Diverse portfolio across the continuum of care

Robust portfolio to meet your patient care needs from delivery rooms to surgery centers and life’s critical moments in between. Our team works with customers to identify the most in-demand presentations to mitigate staff and drug shortages.

Our guiding principles and business segments

Customer is #1

We always deliver excellent customer service! Our expertise, dedication and passion serve to improve the quality of life of patients around the world.

Speed of execution

We act with urgency, work smart and have the courage to change course when needed.

Entrepreneurship

We take ownership, possess an entrepreneurial spirit and challenge our peers.

Creativity

We are problem solvers, relentlessly pursuing innovation and continuous improvement.

Quality

We aim to deliver excellence — nothing less will do. Quality is our center, ingrained in our work, culture and vision.

Fagron Lab

Our global product line of compounding equipment specially designed and developed by Fagron, for the needs of modern compounding pharmacies.

Compounding

A globally trusted compounding expert with over three decades of experience, pharmaceutical compounding represents the origin and cornerstone of Fagron.

Fagron Tech

Our healthcare and business development solution for the pharmacy and beyond — offering integrated operational, administrative, financial management systems and more.

Fagron Genomics

Our laboratory services company, focused on providing specific pharmacogenetics and diagnostic molecular analysis for healthcare professionals.

Leadership

Ray Dixon
Senior Vice President, Commercial Operations

More than 20 years of commercial leadership experience supporting patient care, Ray drives commercial operations across FSS.

Jason McGuire
Senior Vice President, Operations

With over 20 years of experience in healthcare and pharmaceuticals, Jason oversees all operations across FSS.

Josh Parks
Senior Director, Quality

With more than 30 years of experience in pharmaceuticals in both Quality and operations roles, Josh oversees the Quality organization for FSS Wichita.

Deborah McHugh
Senior Director, Quality

With over 25 years of Quality experience across diagnostics, biotech/pharmaceuticals, and 503B Outsourcing, Deb oversees the Quality organization for FSS Boston.

Quality is at the center of everything we do

100%

of batches tested for sterility, particulate matter and potency to support patient safety

“Fagron’s willingness to share openly with customers our metrics, SOPs and processes, and provide virtual tours is key to closing the gap between their understanding of and our execution of cGMPs”
Deborah McHugh
Senior Director, Quality, FSS
“Quality is part of our culture at FSS. It’s embedded in every process and procedure, and we are committed to continuously enhancing our standards to lead the way in the industry.”
Josh Parks
Senior Director, Quality, FSS

24/7/365

State-of-the-art environmental monitoring

Frequently asked questions

Do you use FDA approved devices for final packaging of sterile products?

Fagron Sterile Services US utilizes only FDA approved equipment, containers, and closure devices in the processing and packaging of all compounded sterile preparations.

Do you have access to a technical support team that can help with formulation questions?

Fagron Sterile Services US employs pharmacists that can be reached 24/7 to field your drug-specific questions.

Do you meet or exceed United States Pharmacopoeia recommendations for sterile product compounding?

Fagron Sterile Services US has FDA registered Outsourcing Facilities. These facilities must meet cGMP standards (21CFR 210 & 211) - USP <797> requirements are not applicable for these facilities.

Do you use appropriate grades of pharmaceutical powders when compounding sterile products?

All Fagron Sterile Services US products are compounded from API obtained from FDA registered manufacturers. All API is tested prior to release and use for compounding to ensure they meet compendial specifications.

What is the typical turnaround time from order to delivery?

Monday: Orders placed before 12:00 PM (CST) will ship the same day.

Tuesday - Friday: Orders placed before 2:00 PM (CST) will ship the same day.

Delivery: Time is dependent on the method of delivery chosen.

Note: Refrigerated products will only ship Monday through Wednesday, unless overnight shipping is requested on Thursday (for an additional charge).

Do you have a quality assurance/quality control program in place for final testing of your sterile products and validation of your processes?

Fagron Sterile Services US primarily uses an internal team for all validation activities and an internal laboratory to complete all final testing of our CSPs. Any external support needed has been qualified and approved by our quality team before acceptance.

Have you had specific training in sterile 503B compounding?

The staff at Fagron Sterile Services US (FSS) has been thoroughly trained in sterile product compounding. No operator is allowed to perform sterile compounding activities until they have demonstrated competency for their job requirements and completed the appropriate training.

Still have questions?

We are here to help. Call, email, or schedule a site visit today.

Speak with your personal representative today

Service is in our name and we can’t wait to partner with your patient-focused healthcare facility. Schedule a free consultation today to discuss your 503B outsourcing needs.

Globally and vertically integrated operations

Fagron’s 4k+ employees serve 30+ countries from 70+ facilities

Proactively supporting supply chain resiliency

Fagron’s global team of 100 supply chain experts leverage 3k+ suppliers

Diverse portfolio across the continuum of care

FSS supports patient care from the delivery room to the O.R.
including clinics